BMS-754807
BMS-754807 Uses, Dosage, Side Effects, Food Interaction and all others data.
BMS-754807 is under investigation in clinical trial NCT00908024 (Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors).
| Trade Name | BMS-754807 |
| Generic | BMS-754807 |
| Type | |
| Formula | C23H24FN9O |
| Weight | Average: 461.4948 Monoisotopic: 461.20878464 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here BMS-754807
